Patents Assigned to Tu Therapeutics Inc.
  • Patent number: 11571481
    Abstract: The present disclosure relates to a systemically administered peptide delivery platform that biodistributes to the kidney or urinary tract. The disclosure further relates to methods of treating a disease of the kidney or urinary tract in a subject in need thereof.
    Type: Grant
    Filed: December 20, 2021
    Date of Patent: February 7, 2023
    Assignees: Cornell University, Tu Therapeutics Inc.
    Inventors: Shek Hang Benedict Law, Vanessa Bellat, Benjamin Byung-min Choi